Atlas FDA

ASPIRE Cristalle Digital Breast Tomosynthesis (DBT) Option

FDA premarket approval P160031/S004 · decided 2023-02-13

Approval details

PMA number
P160031
Supplement
S004
Supplement type
Real-Time Process
Supplement reason
Change Design/Components/Specifications/Material
Trade name
ASPIRE Cristalle Digital Breast Tomosynthesis (DBT) Option
Generic name
Digital breast tomosynthesis
Applicant
Fujifilm Medical Systems U.S.A, Inc.
Date received
2022-11-15
Decision date
2023-02-13
Days to decision
90 days
Decision code
APPR
Product code
OTE
Advisory committee
Radiology
Expedited review
No
Location
Stamford, CT
Statement
Approval for the introduction of a higher dose setting (H-mode) for the DBT option.

Class III intelligence, same tools

PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.

510(k) clearances by this applicant

RecordFirmDate
FUJIFILM Bronchoscope Model EB-530P (K171291)Fujifilm Medical Systems U.S.A, Inc.2018-01-19
FUJIFILM Ultrasonic Processor SP-900 and FUJIFILM Ultrasonic Probe PB2020-M (K171207)Fujifilm Medical Systems U.S.A, Inc.2018-01-11
ASPIRE Cristalle (K173132)Fujifilm Medical Systems U.S.A, Inc.2017-10-27
ASPIRE Bellus II (K171463)Fujifilm Medical Systems U.S.A, Inc.2017-09-29
Fujifilm Duodenoscope Model ED-530XT (K152257)Fujifilm Medical Systems U.S.A, Inc.2017-07-21
Dynamic Visualization II Image Processing Option for the FDX Console (DR-ID300CL of the DR-ID600) (K163624)Fujifilm Medical Systems U.S.A, Inc.2017-06-30
FUJIFILM Hood Models DH-28GR, DH-29CR and DH-30CR (K162749)Fujifilm Medical Systems U.S.A, Inc.2017-06-15
Fujifilm Diathermic Slitter (FlushKnife) (K171096)Fujifilm Medical Systems U.S.A, Inc.2017-05-09